3Goepel C, Stoerer S, Koelbl H. Tenascin in preinvasive lesions of the vulva and vulvar cancer [J]. Anticancer Res, 2003,23(6c) :4587-4591.
4Brunner A, Mayerl C, Tzankov A, et al. Prognostic significance of tenascin-C expression in superficial and invasive bladder cancer[J]. J Clin Pathol, 2004,57:927-931.
5Atula T, Hedstrom J, Finne P, et al. Tenascin-C expression and its prognostic significance in oral and pharyngeal squamous cell carcinoma [J]. Anticancer Res, 2003, 23(3c):3051-3056.
6Iskaros BF, Hu X, Sparano JA, et al. Tenascin pattern of expression and established prognostic factors in invasive breast carcinoma [J]. J Surg Oncol,1998, 68(2):107-112.
7Hanahan D, Folkman J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis [J]. Cell, 1996, 86(3) :353-364.
8London WT,EvansM, Buctow K, ct al. Molccular and gcnctic cpidcmiology of hcpatoccllular carcinoma:studics in China and Scncgal[J] Princcss Takamtsu Symp,1995,25:51～60.
9Katakura H, Tanaka F, Oyanagi H, et al. Clinnical sinnificance of nm23 expression in resected pathologic stage I, non small cell lung cancer. [J] Ann Thorac Surg, 2002,73:1060～1064.
10Vogelstein B, Lane D, Levine AJ. Surfing the p53network. Naturer, 2000,408:307～310.
